Alliancebernstein L.P. Stoke Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$280 Billion
Q4 2024

A detailed history of Alliancebernstein L.P. transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 40,630 shares of STOK stock, worth $336,822. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,630

Previous 40,630 -0.0%

Holding current value

$336,822

Previous $499,000 10.22%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$11.03 - $17.52 $36,288 - $57,640	3,290 Added 8.81%	40,630 $548,000
Q4 2023 Feb 14, 2024	SELL	$3.37 - $5.4 $13,412 - $21,492	-3,980 Reduced 9.63%	37,340 $196,000
Q2 2023 Aug 15, 2023	BUY	$7.93 - $13.82 $51,703 - $90,106	6,520 Added 18.74%	41,320 $439,000
Q1 2023 May 15, 2023	BUY	$7.65 - $10.38 $33,660 - $45,672	4,400 Added 14.47%	34,800 $289,000
Q4 2022 Feb 14, 2023	BUY	$7.07 - $15.69 $20,503 - $45,501	2,900 Added 10.55%	30,400 $280,000
Q3 2022 Nov 15, 2022	BUY	$12.56 - $22.53 $47,728 - $85,614	3,800 Added 16.03%	27,500 $353,000
Q2 2022 Aug 15, 2022	BUY	$10.36 - $23.93 $40,404 - $93,327	3,900 Added 19.7%	23,700 $313,000
Q4 2021 Feb 14, 2022	BUY	$18.11 - $30.72 $21,732 - $36,864	1,200 Added 6.45%	19,800 $475,000
Q3 2021 Nov 10, 2021	SELL	$23.65 - $34.44 $28,380 - $41,328	-1,200 Reduced 6.06%	18,600 $473,000
Q2 2021 Jul 30, 2021	BUY	$30.53 - $41.09 $51,901 - $69,853	1,700 Added 9.39%	19,800 $666,000
Q1 2021 May 06, 2021	BUY	$36.08 - $69.81 $25,256 - $48,867	700 Added 4.02%	18,100 $703,000
Q4 2020 Feb 08, 2021	SELL	$33.62 - $61.93 $110,945 - $204,369	-3,300 Reduced 15.94%	17,400 $1.08 Million
Q3 2020 Nov 12, 2020	SELL	$22.23 - $37.48 $26,676 - $44,975	-1,200 Reduced 5.48%	20,700 $693,000
Q2 2020 Aug 13, 2020	BUY	$20.26 - $29.73 $93,196 - $136,758	4,600 Added 26.59%	21,900 $522,000
Q1 2020 May 14, 2020	BUY	$16.8 - $34.15 $290,640 - $590,795	17,300 New	17,300 $396,000

Others Institutions Holding STOK

# of Institutions

135

Shares Held

57.2M

Call Options Held

5.7K

Put Options Held

24.4K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $327M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Stoke Therapeutics, Inc. Transaction History